Increasing research initiatives in head and neck cancer over the past 5 years have resulted in the identification of several 'new' biologic parameters which may be of prognostic importance. This review discusses the limitations of traditional parameters and outlines several promising developments in the study of proliferation markers, molecular biology, immunobiology and flow cytometry as they relate to head and neck cancer.